| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |